These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 17914096

  • 1. HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells.
    Hsu MC, Chang HC, Hung WC.
    Endocr Relat Cancer; 2007 Sep; 14(3):655-67. PubMed ID: 17914096
    [Abstract] [Full Text] [Related]

  • 2. GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation.
    Bai T, Luoh SW.
    Carcinogenesis; 2008 Mar; 29(3):473-9. PubMed ID: 17916906
    [Abstract] [Full Text] [Related]

  • 3. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
    Nguyen A, Rosner A, Milovanovic T, Hope C, Planutis K, Saha B, Chaiwun B, Lin F, Imam SA, Marsh JL, Holcombe RF.
    Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
    [Abstract] [Full Text] [Related]

  • 4. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.
    Esteva FJ, Sahin AA, Rassidakis GZ, Yuan LX, Smith TL, Yang Y, Gilcrease MZ, Cristofanilli M, Nahta R, Pusztai L, Claret FX.
    Clin Cancer Res; 2003 Nov 15; 9(15):5652-9. PubMed ID: 14654548
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bcr-Abl oncogene stimulates Jab1 expression via cooperative interaction of β-catenin and STAT1 in chronic myeloid leukemia cells.
    Yang KT, Wang MC, Chen JY, Hsu MC, Hung WC.
    J Cell Physiol; 2011 Nov 15; 226(11):2849-56. PubMed ID: 21935931
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1.
    Hwang CY, Ryu YS, Chung MS, Kim KD, Park SS, Chae SK, Chae HZ, Kwon KS.
    Oncogene; 2004 Nov 25; 23(55):8868-75. PubMed ID: 15480426
    [Abstract] [Full Text] [Related]

  • 11. A genomic explanation connecting "Mediterranean diet", olive oil and cancer: oleic acid, the main monounsaturated fatty acid of olive oil, induces formation of inhibitory "PEA3 transcription factor-PEA3 DNA binding site" complexes at the Her-2/neu (erbB-2) oncogene promoter in breast, ovarian and stomach cancer cells.
    Menendez JA, Papadimitropoulou A, Vellon L, Lupu R.
    Eur J Cancer; 2006 Oct 25; 42(15):2425-32. PubMed ID: 16406575
    [Abstract] [Full Text] [Related]

  • 12. Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway.
    Yan J, Yu CT, Ozen M, Ittmann M, Tsai SY, Tsai MJ.
    Cancer Res; 2006 Nov 15; 66(22):11039-46. PubMed ID: 17108143
    [Abstract] [Full Text] [Related]

  • 13. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
    Lue H, Thiele M, Franz J, Dahl E, Speckgens S, Leng L, Fingerle-Rowson G, Bucala R, Lüscher B, Bernhagen J.
    Oncogene; 2007 Aug 02; 26(35):5046-59. PubMed ID: 17310986
    [Abstract] [Full Text] [Related]

  • 14. Transactivation of vimentin by beta-catenin in human breast cancer cells.
    Gilles C, Polette M, Mestdagt M, Nawrocki-Raby B, Ruggeri P, Birembaut P, Foidart JM.
    Cancer Res; 2003 May 15; 63(10):2658-64. PubMed ID: 12750294
    [Abstract] [Full Text] [Related]

  • 15. Blocking HER-2/HER-3 function with a dominant negative form of HER-3 in cells stimulated by heregulin and in breast cancer cells with HER-2 gene amplification.
    Ram TG, Schelling ME, Hosick HL.
    Cell Growth Differ; 2000 Mar 15; 11(3):173-83. PubMed ID: 10768865
    [Abstract] [Full Text] [Related]

  • 16. Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells.
    Shackleford TJ, Zhang Q, Tian L, Vu TT, Korapati AL, Baumgartner AM, Le XF, Liao WS, Claret FX.
    Breast Cancer Res; 2011 Jun 20; 13(3):R65. PubMed ID: 21689417
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation.
    Menendez JA, Mehmi I, Verma VA, Teng PK, Lupu R.
    Mol Carcinog; 2004 Nov 20; 41(3):164-78. PubMed ID: 15390078
    [Abstract] [Full Text] [Related]

  • 18. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1).
    Kouvaraki MA, Rassidakis GZ, Tian L, Kumar R, Kittas C, Claret FX.
    Cancer Res; 2003 Jun 01; 63(11):2977-81. PubMed ID: 12782606
    [Abstract] [Full Text] [Related]

  • 19. BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1).
    Williamson EA, Wolf I, O'Kelly J, Bose S, Tanosaki S, Koeffler HP.
    Oncogene; 2006 Mar 02; 25(9):1391-9. PubMed ID: 16331276
    [Abstract] [Full Text] [Related]

  • 20. Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1.
    Jeon JH, Lee KN, Hwang CY, Kwon KS, You KH, Choi I.
    Cancer Res; 2005 Jun 01; 65(11):4485-9. PubMed ID: 15930262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.